Sanofi to pay Regeneron $462 million in revised immuno-oncology deal
The two companies said the new arrangement would give Sanofi increased flexibility to advance its early-stage immuno-oncology…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
HC sets aside Centre’s ban on anti-inflammatory medicine ‘Ace Proxyvon’
This is the first petition, filed against the Health Ministry's notification, to be decided by the court
Antares Vision and ALP.I in agreement
The general meeting to approve the business combination will be held in February 2019
Lupin gets US FDA nod for generic schizophrenia drug
The drug is a generic version os Sunovion Pharmaceuticals' Latuda tablets
Eris Lifesciences collaborates with Medtronic
The two companies will utilise their respective strengths in helping patients monitor their diabetes better
A collaborative…
PharmaHopers launches derma franchise category for B2B businesses
PharmaHopers, based on the market research and study, claims to provide good business opportunities in the dermatology sector by…
Overview of API market
Saurabh Gurnurkar, Executive Director, UQUIFA, talks about the developments in pharma / API industry, what went wrong and what was…
India Pharma 2019, India Medical Device 2019 to be held in Bengaluru on February 18 and 19
The event will see the participation of some of the biggest names in the Indian pharma and medical devices industry
LANXESS completes sale of ARLANXEO to Saudi Aramco
Cologne-based company receives proceeds of around euro 1.4 billion
Sun Pharma acquires Japan’s Pola Pharma
To strengthen its presence in dermatology segment across the globe